Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics

Home › Buy Trovagene To Hedge Patent Risk In Molecular Diagnostics

Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap.

20.05	USDA moves to electronic identification tags
20.05	Better pasture and hay conditions anticipated for 2024
20.05	Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05	Eutelsat reports results for the period ended 31 March 2024
20.05	Producers to be paid grid premiums for AngusLink Beef Scores
20.05	WCC Re-elects Tom Bowtell for Second Term as President, Recognizes Contributions of Andy Doyle
20.05	May/June 2024 Digital Edition of National Hog Farmer now available
20.05	DKSH Extends Distribution Agreement with KRONOS in Asia Pacific
More »

je.st